GUARDIAN-101: A Phase 1 Dose Escalation and Expansion Study of CLSP-1025 in Adult Patients with Solid Tumors that Harbor the p53 R175H Mutation
Clinical Trial Grant
Awarded By
Clasp Therapeutics, Inc
Start Date
December 23, 2025
End Date
December 21, 2030
Awarded By
Clasp Therapeutics, Inc
Start Date
December 23, 2025
End Date
December 21, 2030